Skip to main content
U.S. Department of Health and Human Services
—
National Institutes of Health
Create Account
Login
Main menu
Discover
Share
Create
Learn
Crystallization and X-ray Diffraction Data Collection of Importin-alpha from Mus musculus Complexed with a XPG NLS Peptide, fragment 1
Autogenerated by
for
nevitdilmen
Created on Mon, 2016-03-07 11:15, last updated on Mon, 2016-03-07 11:15
I Printed This
Remix It
Vertical Tabs
General Information
This Model was autogenerated from the
"Quick Submit"
tool.
Model ID
3DPX-002996
Category
Proteins, Macromolecules and Viruses
Keyword(s)
Importin alpha, nuclear import pathway, nuclear localization sequence (NLS), DNA repair proteins, NUCLEOTIDE EXCISION REPAIR, XPG protein, PROTEIN BINDING
Protein Data Bank ID
5EKF
Experimental Method
X-RAY DIFFRACTION
Resolution
1.964
Model Details
Associated Species
Escherichia coli
Oligomeric Details
trimeric
R-Factor
0.1720
Scattering Type
x-ray
Attribution
PubMed ID
26 812 207
Digital Object Identifier (DOI)
10.1016/j.jmb.2016.01.019
Citation Title
Structural and calorimetric studies demonstrate that Xeroderma pigmentosum type G (XPG) can be imported to the nucleus by a classical nuclear import pathway via a monopartite NLS sequence.
Citation Year
2016
STL/VRML Files
PDB-5EKF-ribbon-secondary.wrl
PDB-5EKF-ribbon-rainbow.wrl
PDB-5EKF-ribbon-bychain.wrl
PDB-5EKF-ribbon.stl
PDB-5EKF-ribbon-thick.stl
PDB-5EKF-surf-bychain.wrl
PDB-5EKF-surf-hydropathy.wrl
PDB-5EKF-surf-coulombic.wrl
PDB-5EKF-surf.stl
PDB-5EKF.zip
X3D Files
PDB-5EKF-ribbon-secondary.x3d
PDB-5EKF-ribbon-rainbow.x3d
PDB-5EKF-ribbon-bychain.x3d
PDB-5EKF-ribbon.x3d
PDB-5EKF-ribbon-thick.x3d
PDB-5EKF-surf-bychain.x3d
PDB-5EKF-surf-hydropathy.x3d
PDB-5EKF-surf-coulombic.x3d
PDB-5EKF-surf.x3d
Blender Files
PDB-5EKF-ribbon-secondary.blend
PDB-5EKF-ribbon-rainbow.blend
PDB-5EKF-ribbon-bychain.blend
PDB-5EKF-ribbon.blend
PDB-5EKF-ribbon-thick.blend
PDB-5EKF-surf-bychain.blend
PDB-5EKF-surf-hydropathy.blend
PDB-5EKF-surf-coulombic.blend
PDB-5EKF-surf.blend
Rating
1
Average:
1
(
1
vote)
Licensing
Comments
0